UK markets closed

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (2291.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
19.600+2.000 (+11.36%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 6.80B
Enterprise value 5.41B
Trailing P/E 40.55
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)18.98
Price/book (mrq)3.21
Enterprise value/revenue 15.10
Enterprise value/EBITDA 26.01

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-21.29%
S&P500 52-week change 323.76%
52-week high 335.500
52-week low 313.000
50-day moving average 320.906
200-day moving average 325.861

Share statistics

Avg vol (3-month) 3206.22k
Avg vol (10-day) 3577.5k
Shares outstanding 5346.75M
Implied shares outstanding 6346.75M
Float 865.19M
% held by insiders 180.75%
% held by institutions 10.21%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.63
Forward annual dividend yield 43.19%
Trailing annual dividend rate 30.57
Trailing annual dividend yield 33.24%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 428 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 46.50%
Operating margin (ttm)53.57%

Management effectiveness

Return on assets (ttm)5.42%
Return on equity (ttm)8.26%

Income statement

Revenue (ttm)325.9M
Revenue per share (ttm)0.94
Quarterly revenue growth (yoy)30.20%
Gross profit (ttm)N/A
EBITDA 177.86M
Net income avi to common (ttm)151.53M
Diluted EPS (ttm)0.480
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.27B
Total cash per share (mrq)3.65
Total debt (mrq)2.44M
Total debt/equity (mrq)0.13%
Current ratio (mrq)24.11
Book value per share (mrq)5.56

Cash flow statement

Operating cash flow (ttm)164.26M
Levered free cash flow (ttm)26.85M